{"gene":"MCM9","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":2008,"finding":"MCM9 binds chromatin in an ORC-dependent manner and is required for recruitment of the MCM2-7 helicase onto chromatin; MCM9 forms a stable complex with the licensing factor Cdt1, preventing excess geminin on chromatin during the licensing reaction, acting as an essential activating linker between Cdt1 and the MCM2-7 complex.","method":"Xenopus egg extract depletion, chromatin fractionation, Co-immunoprecipitation, in vitro reconstitution","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in single lab; later work in Xenopus did not replicate the Cdt1 interaction","pmids":["18657502"],"is_preprint":false},{"year":2012,"finding":"MCM8 and MCM9 form a complex; MCM9 knockout mice are sterile (females lack oocytes, males have reduced spermatozoa); MCM8/9-deficient embryonic fibroblasts show impaired chromatin recruitment of HR factors RAD51 and RPA, strongly reduced homologous recombination, and inability to overcome transient replication fork inhibition; MCM8 and MCM9 co-regulate each other's stability.","method":"Knockout mouse generation, co-immunoprecipitation, immunofluorescence, HR reporter assay, Western blot for protein stability","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, replicated across labs, in vivo and cellular phenotypes","pmids":["22771120"],"is_preprint":false},{"year":2012,"finding":"MCM8 and MCM9 form a complex required for homologous recombination repair induced by DNA interstrand crosslinks (ICLs); MCM8-9 forms nuclear foci that colocalize with RAD51; MCM8-9 acts downstream of the FA and BRCA2/RAD51 pathways and is required for HR-promoted sister chromatid exchanges, functioning probably as a hexameric ATPase/helicase.","method":"Chicken DT40 cell knockouts, ICL sensitivity assays, immunofluorescence for nuclear foci, epistasis analysis with FA/BRCA2 pathway mutants, sister chromatid exchange assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis plus multiple cellular assays, replicated across organisms","pmids":["22771115"],"is_preprint":false},{"year":2011,"finding":"MCM9 is dispensable for MCM2-7 loading and DNA replication in vivo; MCM9-deficient cells show elevated genomic instability and defective cell cycle re-entry following replication stress; MCM9 mutant mice show p53-independent embryonic germ-cell depletion in both sexes and males exhibit defective spermatogonial stem-cell renewal.","method":"Knockout mouse generation and phenotypic analysis, cell proliferation assays, replication stress experiments","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — in vivo knockout with defined cellular and organismal phenotypes, multiple readouts","pmids":["21987787"],"is_preprint":false},{"year":2013,"finding":"MCM8 and MCM9 physically associate with each other; MCM8 is required for the stability of MCM9 protein; depletion of MCM8 or MCM9 reduces HR repair efficiency and sensitizes cells to ICL agents; MCM8 and MCM9 are rapidly recruited to DNA damage sites and promote RAD51 recruitment, as shown by ChIP in human DR-GFP cells and Xenopus egg extract.","method":"Co-immunoprecipitation, HR reporter (DR-GFP) assay, chromatin immunoprecipitation, Xenopus egg extract, Western blot, cisplatin sensitivity assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, replicated across human cells and Xenopus, consistent with independent labs","pmids":["23401855"],"is_preprint":false},{"year":2013,"finding":"In Xenopus laevis egg extract, MCM8 and MCM9 form a dimeric complex; they associate with chromatin at later stages of DNA replication and this association is stimulated by DNA damage; MCM9 is not essential for loading of MCM2-7 complex onto chromatin during origin licensing and does not detectably interact with Cdt1 in this system.","method":"Xenopus egg extract, co-immunoprecipitation, chromatin fractionation, DNA damage treatment","journal":"Cell cycle","confidence":"Medium","confidence_rationale":"Tier 2 — single lab, multiple orthogonal methods; partially contradicts earlier Xenopus Cdt1 finding","pmids":["23518502"],"is_preprint":false},{"year":2015,"finding":"MCM9 forms a complex with MMR initiation proteins (MSH2, MSH3, MLH1, PMS1, and the clamp loader RFC) and is essential for DNA mismatch repair; the MCM9 complex has intrinsic helicase activity required for MMR (helicase-dead MCM9 fails to restore MMR in Mcm9-/- cells); MCM9 loading onto chromatin is MSH2-dependent; in turn, MCM9 stimulates recruitment of MLH1 to chromatin; Mcm9-/- cells display microsatellite instability.","method":"Co-immunoprecipitation, MMR activity assay in cell extracts, helicase-dead mutagenesis, chromatin fractionation, microsatellite instability assay, Mcm9 knockout cells","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro helicase assay with active-site mutagenesis, multiple orthogonal methods, KO rescue experiment","pmids":["26300262"],"is_preprint":false},{"year":2014,"finding":"Human MCM9 splice-site variant (c.1732+2T>C) causes abnormal alternative splicing and truncated MCM9 forms that cannot be recruited to sites of DNA damage; a nonsense variant (p.Arg132*) causes loss of functional MCM9; both result in impaired chromosome break repair in patient lymphocytes, establishing MCM9 function in HR in human somatic cells.","method":"Whole-exome sequencing, splicing analysis, DNA damage recruitment assay (patient lymphocytes), chromosome break repair assay","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — functional validation of patient variants by direct recruitment and repair assays","pmids":["25480036"],"is_preprint":false},{"year":2019,"finding":"HROB (C17orf53) is an OB-fold-containing factor that recruits the MCM8-MCM9 helicase to sites of DNA damage to promote recombination-associated DNA synthesis; the HROB-MCM8-MCM9 pathway acts redundantly with the HELQ helicase; combined loss of HROB and HELQ severely impairs HR, placing HROB upstream of MCM8-MCM9 in the HR pathway.","method":"Co-immunoprecipitation, HR reporter assay, immunofluorescence for foci, mouse knockout (infertility/meiotic arrest phenotype), epistasis analysis with HELQ double KO","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — epistasis, reciprocal Co-IP, cellular HR assays, and in vivo phenotype in multiple labs' context","pmids":["31467087"],"is_preprint":false},{"year":2020,"finding":"HORMAD1 interacts with the MCM8-MCM9 complex and prevents its efficient nuclear localization; HORMAD1-expressing cancer cells consequently have reduced MLH1 chromatin binding and DNA mismatch repair defects.","method":"Co-immunoprecipitation, immunofluorescence for nuclear localization, chromatin fractionation for MLH1, MMR assay in cancer cells with/without HORMAD1 expression","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — single lab, multiple orthogonal methods linking HORMAD1 interaction to MCM8-MCM9 nuclear localization and MMR function","pmids":["32647118"],"is_preprint":false},{"year":2021,"finding":"The MCM9 C-terminal extension (CTE) contains a bipartite-like nuclear localization signal (NLS) required for nuclear import of both MCM8 and MCM9, and a variant BRC motif (BRCv) required for localization to MMC-induced DNA damage sites; the MCM9-BRCv directly interacts with and recruits RAD51 to MMC-induced damage.","method":"Mutagenesis of NLS and BRCv motifs, immunofluorescence for nuclear localization and RAD51 foci, co-immunoprecipitation, MCM9 knockout cells, patient lymphocyte RAD51 foci assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — domain mutagenesis combined with direct interaction assay and KO cellular phenotype","pmids":["33539926"],"is_preprint":false},{"year":2015,"finding":"MCM9 deficiency causes reduced primordial germ cell proliferation (not apoptosis) that is independent of the ATM-CHK2-TRP53-P21 signaling pathway; germ cell depletion in Mcm9/Fancm double mutants is additive, indicating MCM9 and FANCM trigger distinct DDR pathways.","method":"Mouse genetics, PGC counting, BrdU proliferation assay, apoptosis assay, double-mutant epistasis analysis","journal":"Genesis","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis in vivo with defined cellular phenotype readout","pmids":["26388201"],"is_preprint":false},{"year":2005,"finding":"MCM9 is a novel vertebrate-specific MCM family protein containing an MCM8-like ATP binding and hydrolysis motif (helicase activity motif) and a unique conserved carboxy-terminal domain absent in MCM2-8; it belongs to a distinct MCM subgroup with MCM8.","method":"Bioinformatics/sequence analysis, phylogenetic analysis, domain identification","journal":"Gene","confidence":"Low","confidence_rationale":"Tier 4 — computational/sequence analysis only, no functional experiment","pmids":["16226853"],"is_preprint":false},{"year":2025,"finding":"MCM8/9 physically interacts with FANCD2 through its core domain independently of DNA; FANCD2 is essential for recruitment of MCM9 to ICL-induced nuclear foci, downstream of FANCD2 monoubiquitination; MCM8/9 ATPase activity and BRCv motif are required for foci formation but not for FANCD2 binding; combined loss of MCM9 and FANCD2 is epistatic, placing MCM8/9 as a downstream effector in the FA pathway.","method":"Co-immunoprecipitation, immunofluorescence for nuclear foci, MCM8/9 and FANCD2 knockout cells, γH2AX assay, cell survival assay, epistasis analysis","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods, epistasis, but preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.08.07.669127"],"is_preprint":true},{"year":2025,"finding":"Human MCM9 interacts with MSH2 and MLH1 in testicular tissue; MCM9 is predominantly expressed in spermatogonial stem cells and spermatogonia; MCM9 loss-of-function mutations impair HR-mediated DNA repair capacity in HEK293T cells and cause Sertoli cell-only syndrome in human males.","method":"Co-immunoprecipitation (human testis), immunohistochemistry for MCM9 localization, HR repair assay in KO and mutant-overexpressing HEK293T cells","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 — direct protein interaction in human tissue plus functional repair assay, single study","pmids":["40593474"],"is_preprint":false}],"current_model":"MCM9 is a vertebrate-specific MCM-family ATPase/helicase that forms a heterohexameric complex with MCM8; this complex is recruited to stalled replication forks and DNA double-strand breaks through an HROB-mediated loading mechanism and via a BRC-variant motif in MCM9's disordered C-terminal extension that directly engages RAD51, thereby promoting recombination-associated DNA synthesis downstream of the FA pathway and RAD51 loading; independently, MCM9 assembles with MMR initiation factors (MSH2, MLH1, PMS1, RFC) and its intrinsic helicase activity is required for mismatch repair, with MSH2-dependent chromatin loading of MCM9 in turn stimulating MLH1 chromatin recruitment, making MCM9 essential for both homologous recombination and mismatch repair, functions that are especially critical during gametogenesis where its loss causes sterility."},"narrative":{"teleology":[{"year":2005,"claim":"Identification of MCM9 as a vertebrate-specific MCM family member with predicted helicase motifs and a unique C-terminal domain established it as a candidate replicative or repair helicase distinct from MCM2-7.","evidence":"Bioinformatic and phylogenetic analysis of MCM family sequences","pmids":["16226853"],"confidence":"Low","gaps":["No experimental validation of helicase activity or cellular function","Computational prediction only"]},{"year":2008,"claim":"An early study proposed MCM9 as a licensing cofactor that binds Cdt1 and is required for MCM2-7 loading, suggesting a replication-initiation role; however, this model was not confirmed in subsequent studies.","evidence":"Xenopus egg extract depletion, chromatin fractionation, co-immunoprecipitation","pmids":["18657502"],"confidence":"Medium","gaps":["Cdt1 interaction was not replicated in a later Xenopus system","Role in MCM2-7 loading contradicted by knockout mouse data"]},{"year":2012,"claim":"Three independent studies established that MCM9 is dispensable for replication licensing but essential for homologous recombination: MCM8-MCM9 form a complex that promotes RAD51/RPA recruitment to damage sites, acts downstream of the FA/BRCA2 pathways, and is required for germ-cell maintenance, resolving the functional identity of MCM9 as a repair helicase.","evidence":"Knockout mice (sterility, germ-cell depletion), chicken DT40 knockouts (ICL sensitivity, epistasis with FA/BRCA2), HR reporter assays, immunofluorescence for RAD51/RPA foci","pmids":["22771120","22771115","21987787","23518502"],"confidence":"High","gaps":["Mechanism of MCM8-MCM9 recruitment to damage sites unknown","Whether the complex functions as a hexamer in vivo unresolved","Direct helicase activity not yet demonstrated biochemically"]},{"year":2013,"claim":"Confirmation in human cells that MCM8-MCM9 are rapidly recruited to DNA damage sites and promote RAD51 recruitment via ChIP, and that MCM8 stabilizes MCM9 protein, solidified the obligate heteromeric partnership.","evidence":"Co-immunoprecipitation, DR-GFP HR reporter, chromatin immunoprecipitation in human cells and Xenopus extract","pmids":["23401855"],"confidence":"High","gaps":["Direct physical interaction with RAD51 not mapped","Helicase substrate specificity unknown"]},{"year":2014,"claim":"Human patient mutations in MCM9 were shown to produce truncated proteins unable to localize to DNA damage, directly linking MCM9 loss of function to impaired chromosome break repair in human somatic cells.","evidence":"Whole-exome sequencing of patients, splicing analysis, DNA damage recruitment and repair assays in patient lymphocytes","pmids":["25480036"],"confidence":"Medium","gaps":["Small patient cohort","No rescue experiment with wild-type MCM9 in patient cells"]},{"year":2015,"claim":"Discovery that MCM9 assembles with MMR factors (MSH2, MLH1, PMS1, RFC) and that its helicase activity is required for mismatch repair revealed a second, independent genome-maintenance function for MCM9 beyond HR.","evidence":"Co-immunoprecipitation, MMR activity assay in cell extracts, helicase-dead mutagenesis and knockout rescue, microsatellite instability assay","pmids":["26300262"],"confidence":"High","gaps":["Whether MMR and HR functions use the same MCM8-MCM9 complex or distinct assemblies unclear","Biochemical reconstitution of MCM9-dependent MMR not performed","MMR role not yet validated in vivo in mice"]},{"year":2015,"claim":"Genetic epistasis showed MCM9 promotes primordial germ-cell proliferation through a pathway distinct from FANCM, and independently of ATM-CHK2-p53-p21 signaling, refining the understanding of MCM9's gametogenesis role.","evidence":"Mouse genetics, Mcm9/Fancm double mutants, BrdU proliferation and apoptosis assays","pmids":["26388201"],"confidence":"Medium","gaps":["Identity of the MCM9-dependent proliferation signal unknown","Whether germ-cell defect is solely due to HR or also MMR impairment not distinguished"]},{"year":2019,"claim":"HROB was identified as the factor that loads the MCM8-MCM9 helicase at damage sites, acting redundantly with HELQ, answering the long-standing question of how the complex is recruited to HR intermediates.","evidence":"Co-immunoprecipitation, HR reporter assay, mouse knockout phenocopying MCM8/9 infertility, epistasis with HELQ","pmids":["31467087"],"confidence":"High","gaps":["Structural basis of HROB-MCM8/9 interaction unknown","Whether HROB is also required for MCM9's MMR function not tested"]},{"year":2020,"claim":"HORMAD1 was shown to sequester MCM8-MCM9 and impair its nuclear localization, linking cancer-associated HORMAD1 misexpression to MMR deficiency through MCM9, connecting germ-cell biology to tumor MMR phenotypes.","evidence":"Co-immunoprecipitation, immunofluorescence, chromatin fractionation for MLH1, MMR assay in HORMAD1-expressing cancer cells","pmids":["32647118"],"confidence":"Medium","gaps":["Single-lab observation not independently replicated","HORMAD1-MCM8/9 interaction domain not mapped"]},{"year":2021,"claim":"Mapping of the MCM9 C-terminal extension identified a bipartite NLS required for nuclear import of both MCM8 and MCM9, and a BRC-variant motif that directly binds RAD51, explaining the molecular mechanism by which MCM9 promotes RAD51 recruitment.","evidence":"Domain mutagenesis of NLS and BRCv, immunofluorescence, co-immunoprecipitation, MCM9 knockout and patient cell assays","pmids":["33539926"],"confidence":"High","gaps":["Crystal structure of BRCv-RAD51 interface not determined","Whether BRCv is sufficient for RAD51 filament remodeling unknown"]},{"year":2025,"claim":"MCM9 was shown to interact with MSH2 and MLH1 in human testis and to be enriched in spermatogonial stem cells; loss-of-function mutations cause Sertoli cell-only syndrome in human males, establishing a direct clinical link between MCM9 and male infertility.","evidence":"Co-immunoprecipitation from human testicular tissue, immunohistochemistry, HR repair assay in HEK293T knockout and mutant cells","pmids":["40593474"],"confidence":"Medium","gaps":["Small patient cohort","Whether the infertility phenotype is driven by HR, MMR, or both is unresolved"]},{"year":null,"claim":"Key unresolved questions include the structural basis of MCM8-MCM9 hexamerization and its helicase mechanism on recombination intermediates, whether MMR and HR employ the same or distinct MCM9-containing complexes, and the molecular basis by which MCM9 loss selectively depletes germ cells while leaving somatic viability largely intact.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of the MCM8-MCM9 complex","In vivo reconstitution of MCM9-dependent MMR not performed","Tissue-specific regulation of MCM9 expression poorly characterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[2,6,12]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[6]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,2,4,10]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[0,4,5,6]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[1,2,4,6,8,10]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[6,7,14]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[1,3,14]}],"complexes":["MCM8-MCM9 helicase complex","MCM9-MSH2-MLH1-PMS1-RFC MMR complex"],"partners":["MCM8","MSH2","MLH1","PMS1","RAD51","HROB","FANCD2","HORMAD1"],"other_free_text":[]},"mechanistic_narrative":"MCM9 is a vertebrate-specific MCM-family ATPase/helicase that functions in both homologous recombination (HR) and DNA mismatch repair (MMR) by forming obligate complexes with distinct partner sets. MCM9 heterodimerizes with MCM8 to form a helicase complex that is recruited by HROB to stalled replication forks and DNA interstrand crosslinks downstream of the Fanconi anemia pathway and FANCD2 monoubiquitination; a variant BRC motif in the MCM9 C-terminal extension directly engages RAD51, promoting its recruitment to damage sites and enabling recombination-associated DNA synthesis [PMID:22771120, PMID:22771115, PMID:31467087, PMID:33539926]. Independently, MCM9 assembles with MMR initiation factors MSH2, MLH1, PMS1, and RFC, and its intrinsic helicase activity is required for mismatch repair, with MSH2-dependent chromatin loading of MCM9 stimulating MLH1 recruitment [PMID:26300262]. Loss-of-function mutations in MCM9 cause gonadal failure and infertility in mice and humans—including Sertoli cell-only syndrome in males—reflecting an essential role in germ-cell proliferation and meiotic recombination [PMID:21987787, PMID:40593474]."},"prefetch_data":{"uniprot":{"accession":"Q9NXL9","full_name":"DNA helicase MCM9","aliases":["DNA 3'-5' helicase MCM9","Mini-chromosome maintenance deficient domain-containing protein 1","Minichromosome maintenance 9"],"length_aa":1143,"mass_kda":127.3,"function":"Component of the MCM8-MCM9 complex, which is involved in the repair of double-stranded DNA breaks (DBSs) and DNA interstrand cross-links (ICLs) by homologous recombination (HR) (PubMed:23401855). The MCM8-MCM9 complex is a 3'-5' DNA helicase and single-stranded (ss)DNA-stimulated ATPase which binds ssDNA in the presence of nucleoside triphosphates (PubMed:37309874). Required for DNA resection by the MRE11-RAD50-NBN/NBS1 (MRN) complex by recruiting the MRN complex to the repair site and by promoting the complex nuclease activity (PubMed:26215093). Indirectly regulates the recruitment of downstream effector RAD51 to DNA damage sites including DBSs and ICLs, probably by regulating the localization of the MNR complex (PubMed:23401855). Acts as a helicase in DNA mismatch repair (MMR) following DNA replication errors to unwind the mismatch containing DNA strand (PubMed:26300262). In addition, recruits MLH1, a component of the MMR complex, to chromatin (PubMed:26300262). The MCM8-MCM9 complex is dispensable for DNA replication and S phase progression (PubMed:23401855). Plays a key role during gametogenesis, probably by regulating HR (By similarity)","subcellular_location":"Nucleus; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q9NXL9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MCM9","classification":"Not Classified","n_dependent_lines":29,"n_total_lines":1208,"dependency_fraction":0.024006622516556293},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"MSH6","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/MCM9","total_profiled":1310},"omim":[{"mim_id":"620897","title":"OVARIAN DYSGENESIS 11; ODG11","url":"https://www.omim.org/entry/620897"},{"mim_id":"618611","title":"HOMOLOGOUS RECOMBINATION FACTOR WITH OB-FOLD; HROB","url":"https://www.omim.org/entry/618611"},{"mim_id":"616185","title":"OVARIAN DYSGENESIS 4; ODG4","url":"https://www.omim.org/entry/616185"},{"mim_id":"610098","title":"MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 9; MCM9","url":"https://www.omim.org/entry/610098"},{"mim_id":"608187","title":"MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 8; MCM8","url":"https://www.omim.org/entry/608187"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MCM9"},"hgnc":{"alias_symbol":["MGC35304","dJ329L24.3","FLJ20170"],"prev_symbol":["MCMDC1","C6orf61"]},"alphafold":{"accession":"Q9NXL9","domains":[{"cath_id":"3.30.1640.10","chopping":"2-103","consensus_level":"medium","plddt":83.0458,"start":2,"end":103},{"cath_id":"2.40.50","chopping":"113-235_258-270","consensus_level":"medium","plddt":82.6315,"start":113,"end":270}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NXL9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NXL9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NXL9-F1-predicted_aligned_error_v6.png","plddt_mean":61.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MCM9","jax_strain_url":"https://www.jax.org/strain/search?query=MCM9"},"sequence":{"accession":"Q9NXL9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NXL9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NXL9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NXL9"}},"corpus_meta":[{"pmid":"22771120","id":"PMC_22771120","title":"MCM8- and MCM9-deficient mice reveal gametogenesis defects and genome instability due to impaired homologous recombination.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22771120","citation_count":174,"is_preprint":false},{"pmid":"25480036","id":"PMC_25480036","title":"MCM9 mutations are associated with ovarian failure, short stature, and chromosomal instability.","date":"2014","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25480036","citation_count":158,"is_preprint":false},{"pmid":"22771115","id":"PMC_22771115","title":"Mcm8 and Mcm9 form a complex that functions in homologous recombination repair induced by DNA interstrand crosslinks.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22771115","citation_count":123,"is_preprint":false},{"pmid":"23401855","id":"PMC_23401855","title":"The MCM8-MCM9 complex promotes RAD51 recruitment at DNA damage sites to facilitate homologous recombination.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23401855","citation_count":110,"is_preprint":false},{"pmid":"27802094","id":"PMC_27802094","title":"MCM8 and MCM9 Nucleotide Variants in Women With Primary Ovarian Insufficiency.","date":"2017","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/27802094","citation_count":87,"is_preprint":false},{"pmid":"21987787","id":"PMC_21987787","title":"Minichromosome maintenance helicase paralog MCM9 is dispensible for DNA replication but functions in germ-line stem cells and tumor suppression.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21987787","citation_count":72,"is_preprint":false},{"pmid":"18657502","id":"PMC_18657502","title":"MCM9 binds Cdt1 and is required for the assembly of prereplication complexes.","date":"2008","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/18657502","citation_count":65,"is_preprint":false},{"pmid":"31467087","id":"PMC_31467087","title":"Control of homologous recombination by the HROB-MCM8-MCM9 pathway.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/31467087","citation_count":62,"is_preprint":false},{"pmid":"26771056","id":"PMC_26771056","title":"A non-sense MCM9 mutation in a familial case of primary ovarian insufficiency.","date":"2016","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26771056","citation_count":60,"is_preprint":false},{"pmid":"26300262","id":"PMC_26300262","title":"MCM9 Is Required for Mammalian DNA Mismatch Repair.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/26300262","citation_count":59,"is_preprint":false},{"pmid":"26806154","id":"PMC_26806154","title":"Mutated MCM9 is associated with predisposition to hereditary mixed polyposis and colorectal cancer in addition to primary ovarian failure.","date":"2015","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26806154","citation_count":49,"is_preprint":false},{"pmid":"16226853","id":"PMC_16226853","title":"Identification of full genes and proteins of MCM9, a novel, vertebrate-specific member of the MCM2-8 protein family.","date":"2005","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/16226853","citation_count":46,"is_preprint":false},{"pmid":"15850810","id":"PMC_15850810","title":"Identification of a novel cell-cycle-induced MCM family protein MCM9.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15850810","citation_count":45,"is_preprint":false},{"pmid":"32647118","id":"PMC_32647118","title":"Aberrantly expressed HORMAD1 disrupts nuclear localization of MCM8-MCM9 complex and compromises DNA mismatch repair in cancer cells.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32647118","citation_count":35,"is_preprint":false},{"pmid":"31509747","id":"PMC_31509747","title":"MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid Tumors.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31509747","citation_count":30,"is_preprint":false},{"pmid":"32145932","id":"PMC_32145932","title":"Novel pathogenic mutations in minichromosome maintenance complex component 9 (MCM9) responsible for premature ovarian insufficiency.","date":"2020","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/32145932","citation_count":28,"is_preprint":false},{"pmid":"23518502","id":"PMC_23518502","title":"Mcm8 and Mcm9 form a dimeric complex in Xenopus laevis egg extract that is not essential for DNA replication initiation.","date":"2013","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23518502","citation_count":26,"is_preprint":false},{"pmid":"33539926","id":"PMC_33539926","title":"Motifs of the C-terminal domain of MCM9 direct localization to sites of mitomycin-C damage for RAD51 recruitment.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33539926","citation_count":21,"is_preprint":false},{"pmid":"26388201","id":"PMC_26388201","title":"MCM9 deficiency delays primordial germ cell proliferation independent of the ATM pathway.","date":"2015","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/26388201","citation_count":21,"is_preprint":false},{"pmid":"37378315","id":"PMC_37378315","title":"Molecular functions of MCM8 and MCM9 and their associated pathologies.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37378315","citation_count":16,"is_preprint":false},{"pmid":"34556653","id":"PMC_34556653","title":"MCM9 is associated with germline predisposition to early-onset cancer-clinical evidence.","date":"2021","source":"NPJ genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34556653","citation_count":12,"is_preprint":false},{"pmid":"33750944","id":"PMC_33750944","title":"The etiology of Down syndrome: Maternal MCM9 polymorphisms increase risk of reduced recombination and nondisjunction of chromosome 21 during meiosis I within oocyte.","date":"2021","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33750944","citation_count":9,"is_preprint":false},{"pmid":"27886675","id":"PMC_27886675","title":"Pathogenic germline MCM9 variants are rare in Australian Lynch-like syndrome patients.","date":"2016","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27886675","citation_count":8,"is_preprint":false},{"pmid":"36769638","id":"PMC_36769638","title":"The Role of MCM9 in the Etiology of Sertoli Cell-Only Syndrome and Premature Ovarian Insufficiency.","date":"2023","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36769638","citation_count":7,"is_preprint":false},{"pmid":"23403237","id":"PMC_23403237","title":"Identification, quantification, and evolutionary analysis of a novel isoform of MCM9.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23403237","citation_count":7,"is_preprint":false},{"pmid":"26870752","id":"PMC_26870752","title":"Proteomic data on the nuclear interactome of human MCM9.","date":"2015","source":"Data in brief","url":"https://pubmed.ncbi.nlm.nih.gov/26870752","citation_count":5,"is_preprint":false},{"pmid":"40593474","id":"PMC_40593474","title":"MCM9 deficiency impairs DNA damage repair during spermatogenesis, leading to Sertoli cell-only syndrome in humans.","date":"2025","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/40593474","citation_count":1,"is_preprint":false},{"pmid":"40684266","id":"PMC_40684266","title":"Clinical syndromes linked to biallelic germline variants in MCM8 and MCM9.","date":"2025","source":"HGG advances","url":"https://pubmed.ncbi.nlm.nih.gov/40684266","citation_count":1,"is_preprint":false},{"pmid":"39447595","id":"PMC_39447595","title":"MCM9 compound heterozygosity in an adolescent with premature ovarian insufficiency.","date":"2024","source":"Endocrinology, diabetes & metabolism case reports","url":"https://pubmed.ncbi.nlm.nih.gov/39447595","citation_count":1,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.08.07.669127","title":"MCM8/9 and FANCD2 interact within a shared pathway in response to replication stress caused by DNA crosslinks","date":"2025-08-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.07.669127","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.30.24315828","title":"Clinical syndromes linked to biallelic germline variants in<i>MCM8</i>and<i>MCM9</i>","date":"2024-11-04","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.30.24315828","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.05.14.594192","title":"Identifying Novel Therapeutic Targets for Overcoming TNBC Chemo Resistance Through Comprehensive CRISPR-Cas9 Genome Screening","date":"2024-05-17","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.14.594192","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":15822,"output_tokens":3792,"usd":0.052173},"stage2":{"model":"claude-opus-4-6","input_tokens":7194,"output_tokens":2931,"usd":0.163867},"total_usd":0.21604,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"MCM9 binds chromatin in an ORC-dependent manner and is required for recruitment of the MCM2-7 helicase onto chromatin; MCM9 forms a stable complex with the licensing factor Cdt1, preventing excess geminin on chromatin during the licensing reaction, acting as an essential activating linker between Cdt1 and the MCM2-7 complex.\",\n      \"method\": \"Xenopus egg extract depletion, chromatin fractionation, Co-immunoprecipitation, in vitro reconstitution\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in single lab; later work in Xenopus did not replicate the Cdt1 interaction\",\n      \"pmids\": [\"18657502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MCM8 and MCM9 form a complex; MCM9 knockout mice are sterile (females lack oocytes, males have reduced spermatozoa); MCM8/9-deficient embryonic fibroblasts show impaired chromatin recruitment of HR factors RAD51 and RPA, strongly reduced homologous recombination, and inability to overcome transient replication fork inhibition; MCM8 and MCM9 co-regulate each other's stability.\",\n      \"method\": \"Knockout mouse generation, co-immunoprecipitation, immunofluorescence, HR reporter assay, Western blot for protein stability\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, replicated across labs, in vivo and cellular phenotypes\",\n      \"pmids\": [\"22771120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MCM8 and MCM9 form a complex required for homologous recombination repair induced by DNA interstrand crosslinks (ICLs); MCM8-9 forms nuclear foci that colocalize with RAD51; MCM8-9 acts downstream of the FA and BRCA2/RAD51 pathways and is required for HR-promoted sister chromatid exchanges, functioning probably as a hexameric ATPase/helicase.\",\n      \"method\": \"Chicken DT40 cell knockouts, ICL sensitivity assays, immunofluorescence for nuclear foci, epistasis analysis with FA/BRCA2 pathway mutants, sister chromatid exchange assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis plus multiple cellular assays, replicated across organisms\",\n      \"pmids\": [\"22771115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MCM9 is dispensable for MCM2-7 loading and DNA replication in vivo; MCM9-deficient cells show elevated genomic instability and defective cell cycle re-entry following replication stress; MCM9 mutant mice show p53-independent embryonic germ-cell depletion in both sexes and males exhibit defective spermatogonial stem-cell renewal.\",\n      \"method\": \"Knockout mouse generation and phenotypic analysis, cell proliferation assays, replication stress experiments\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo knockout with defined cellular and organismal phenotypes, multiple readouts\",\n      \"pmids\": [\"21987787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MCM8 and MCM9 physically associate with each other; MCM8 is required for the stability of MCM9 protein; depletion of MCM8 or MCM9 reduces HR repair efficiency and sensitizes cells to ICL agents; MCM8 and MCM9 are rapidly recruited to DNA damage sites and promote RAD51 recruitment, as shown by ChIP in human DR-GFP cells and Xenopus egg extract.\",\n      \"method\": \"Co-immunoprecipitation, HR reporter (DR-GFP) assay, chromatin immunoprecipitation, Xenopus egg extract, Western blot, cisplatin sensitivity assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, replicated across human cells and Xenopus, consistent with independent labs\",\n      \"pmids\": [\"23401855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In Xenopus laevis egg extract, MCM8 and MCM9 form a dimeric complex; they associate with chromatin at later stages of DNA replication and this association is stimulated by DNA damage; MCM9 is not essential for loading of MCM2-7 complex onto chromatin during origin licensing and does not detectably interact with Cdt1 in this system.\",\n      \"method\": \"Xenopus egg extract, co-immunoprecipitation, chromatin fractionation, DNA damage treatment\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — single lab, multiple orthogonal methods; partially contradicts earlier Xenopus Cdt1 finding\",\n      \"pmids\": [\"23518502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MCM9 forms a complex with MMR initiation proteins (MSH2, MSH3, MLH1, PMS1, and the clamp loader RFC) and is essential for DNA mismatch repair; the MCM9 complex has intrinsic helicase activity required for MMR (helicase-dead MCM9 fails to restore MMR in Mcm9-/- cells); MCM9 loading onto chromatin is MSH2-dependent; in turn, MCM9 stimulates recruitment of MLH1 to chromatin; Mcm9-/- cells display microsatellite instability.\",\n      \"method\": \"Co-immunoprecipitation, MMR activity assay in cell extracts, helicase-dead mutagenesis, chromatin fractionation, microsatellite instability assay, Mcm9 knockout cells\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro helicase assay with active-site mutagenesis, multiple orthogonal methods, KO rescue experiment\",\n      \"pmids\": [\"26300262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Human MCM9 splice-site variant (c.1732+2T>C) causes abnormal alternative splicing and truncated MCM9 forms that cannot be recruited to sites of DNA damage; a nonsense variant (p.Arg132*) causes loss of functional MCM9; both result in impaired chromosome break repair in patient lymphocytes, establishing MCM9 function in HR in human somatic cells.\",\n      \"method\": \"Whole-exome sequencing, splicing analysis, DNA damage recruitment assay (patient lymphocytes), chromosome break repair assay\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional validation of patient variants by direct recruitment and repair assays\",\n      \"pmids\": [\"25480036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HROB (C17orf53) is an OB-fold-containing factor that recruits the MCM8-MCM9 helicase to sites of DNA damage to promote recombination-associated DNA synthesis; the HROB-MCM8-MCM9 pathway acts redundantly with the HELQ helicase; combined loss of HROB and HELQ severely impairs HR, placing HROB upstream of MCM8-MCM9 in the HR pathway.\",\n      \"method\": \"Co-immunoprecipitation, HR reporter assay, immunofluorescence for foci, mouse knockout (infertility/meiotic arrest phenotype), epistasis analysis with HELQ double KO\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis, reciprocal Co-IP, cellular HR assays, and in vivo phenotype in multiple labs' context\",\n      \"pmids\": [\"31467087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"HORMAD1 interacts with the MCM8-MCM9 complex and prevents its efficient nuclear localization; HORMAD1-expressing cancer cells consequently have reduced MLH1 chromatin binding and DNA mismatch repair defects.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence for nuclear localization, chromatin fractionation for MLH1, MMR assay in cancer cells with/without HORMAD1 expression\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — single lab, multiple orthogonal methods linking HORMAD1 interaction to MCM8-MCM9 nuclear localization and MMR function\",\n      \"pmids\": [\"32647118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The MCM9 C-terminal extension (CTE) contains a bipartite-like nuclear localization signal (NLS) required for nuclear import of both MCM8 and MCM9, and a variant BRC motif (BRCv) required for localization to MMC-induced DNA damage sites; the MCM9-BRCv directly interacts with and recruits RAD51 to MMC-induced damage.\",\n      \"method\": \"Mutagenesis of NLS and BRCv motifs, immunofluorescence for nuclear localization and RAD51 foci, co-immunoprecipitation, MCM9 knockout cells, patient lymphocyte RAD51 foci assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — domain mutagenesis combined with direct interaction assay and KO cellular phenotype\",\n      \"pmids\": [\"33539926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MCM9 deficiency causes reduced primordial germ cell proliferation (not apoptosis) that is independent of the ATM-CHK2-TRP53-P21 signaling pathway; germ cell depletion in Mcm9/Fancm double mutants is additive, indicating MCM9 and FANCM trigger distinct DDR pathways.\",\n      \"method\": \"Mouse genetics, PGC counting, BrdU proliferation assay, apoptosis assay, double-mutant epistasis analysis\",\n      \"journal\": \"Genesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo with defined cellular phenotype readout\",\n      \"pmids\": [\"26388201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MCM9 is a novel vertebrate-specific MCM family protein containing an MCM8-like ATP binding and hydrolysis motif (helicase activity motif) and a unique conserved carboxy-terminal domain absent in MCM2-8; it belongs to a distinct MCM subgroup with MCM8.\",\n      \"method\": \"Bioinformatics/sequence analysis, phylogenetic analysis, domain identification\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — computational/sequence analysis only, no functional experiment\",\n      \"pmids\": [\"16226853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MCM8/9 physically interacts with FANCD2 through its core domain independently of DNA; FANCD2 is essential for recruitment of MCM9 to ICL-induced nuclear foci, downstream of FANCD2 monoubiquitination; MCM8/9 ATPase activity and BRCv motif are required for foci formation but not for FANCD2 binding; combined loss of MCM9 and FANCD2 is epistatic, placing MCM8/9 as a downstream effector in the FA pathway.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence for nuclear foci, MCM8/9 and FANCD2 knockout cells, γH2AX assay, cell survival assay, epistasis analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, epistasis, but preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.08.07.669127\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Human MCM9 interacts with MSH2 and MLH1 in testicular tissue; MCM9 is predominantly expressed in spermatogonial stem cells and spermatogonia; MCM9 loss-of-function mutations impair HR-mediated DNA repair capacity in HEK293T cells and cause Sertoli cell-only syndrome in human males.\",\n      \"method\": \"Co-immunoprecipitation (human testis), immunohistochemistry for MCM9 localization, HR repair assay in KO and mutant-overexpressing HEK293T cells\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct protein interaction in human tissue plus functional repair assay, single study\",\n      \"pmids\": [\"40593474\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MCM9 is a vertebrate-specific MCM-family ATPase/helicase that forms a heterohexameric complex with MCM8; this complex is recruited to stalled replication forks and DNA double-strand breaks through an HROB-mediated loading mechanism and via a BRC-variant motif in MCM9's disordered C-terminal extension that directly engages RAD51, thereby promoting recombination-associated DNA synthesis downstream of the FA pathway and RAD51 loading; independently, MCM9 assembles with MMR initiation factors (MSH2, MLH1, PMS1, RFC) and its intrinsic helicase activity is required for mismatch repair, with MSH2-dependent chromatin loading of MCM9 in turn stimulating MLH1 chromatin recruitment, making MCM9 essential for both homologous recombination and mismatch repair, functions that are especially critical during gametogenesis where its loss causes sterility.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MCM9 is a vertebrate-specific MCM-family ATPase/helicase that functions in both homologous recombination (HR) and DNA mismatch repair (MMR) by forming obligate complexes with distinct partner sets. MCM9 heterodimerizes with MCM8 to form a helicase complex that is recruited by HROB to stalled replication forks and DNA interstrand crosslinks downstream of the Fanconi anemia pathway and FANCD2 monoubiquitination; a variant BRC motif in the MCM9 C-terminal extension directly engages RAD51, promoting its recruitment to damage sites and enabling recombination-associated DNA synthesis [PMID:22771120, PMID:22771115, PMID:31467087, PMID:33539926]. Independently, MCM9 assembles with MMR initiation factors MSH2, MLH1, PMS1, and RFC, and its intrinsic helicase activity is required for mismatch repair, with MSH2-dependent chromatin loading of MCM9 stimulating MLH1 recruitment [PMID:26300262]. Loss-of-function mutations in MCM9 cause gonadal failure and infertility in mice and humans—including Sertoli cell-only syndrome in males—reflecting an essential role in germ-cell proliferation and meiotic recombination [PMID:21987787, PMID:40593474].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of MCM9 as a vertebrate-specific MCM family member with predicted helicase motifs and a unique C-terminal domain established it as a candidate replicative or repair helicase distinct from MCM2-7.\",\n      \"evidence\": \"Bioinformatic and phylogenetic analysis of MCM family sequences\",\n      \"pmids\": [\"16226853\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No experimental validation of helicase activity or cellular function\", \"Computational prediction only\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"An early study proposed MCM9 as a licensing cofactor that binds Cdt1 and is required for MCM2-7 loading, suggesting a replication-initiation role; however, this model was not confirmed in subsequent studies.\",\n      \"evidence\": \"Xenopus egg extract depletion, chromatin fractionation, co-immunoprecipitation\",\n      \"pmids\": [\"18657502\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cdt1 interaction was not replicated in a later Xenopus system\", \"Role in MCM2-7 loading contradicted by knockout mouse data\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Three independent studies established that MCM9 is dispensable for replication licensing but essential for homologous recombination: MCM8-MCM9 form a complex that promotes RAD51/RPA recruitment to damage sites, acts downstream of the FA/BRCA2 pathways, and is required for germ-cell maintenance, resolving the functional identity of MCM9 as a repair helicase.\",\n      \"evidence\": \"Knockout mice (sterility, germ-cell depletion), chicken DT40 knockouts (ICL sensitivity, epistasis with FA/BRCA2), HR reporter assays, immunofluorescence for RAD51/RPA foci\",\n      \"pmids\": [\"22771120\", \"22771115\", \"21987787\", \"23518502\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of MCM8-MCM9 recruitment to damage sites unknown\", \"Whether the complex functions as a hexamer in vivo unresolved\", \"Direct helicase activity not yet demonstrated biochemically\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Confirmation in human cells that MCM8-MCM9 are rapidly recruited to DNA damage sites and promote RAD51 recruitment via ChIP, and that MCM8 stabilizes MCM9 protein, solidified the obligate heteromeric partnership.\",\n      \"evidence\": \"Co-immunoprecipitation, DR-GFP HR reporter, chromatin immunoprecipitation in human cells and Xenopus extract\",\n      \"pmids\": [\"23401855\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct physical interaction with RAD51 not mapped\", \"Helicase substrate specificity unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Human patient mutations in MCM9 were shown to produce truncated proteins unable to localize to DNA damage, directly linking MCM9 loss of function to impaired chromosome break repair in human somatic cells.\",\n      \"evidence\": \"Whole-exome sequencing of patients, splicing analysis, DNA damage recruitment and repair assays in patient lymphocytes\",\n      \"pmids\": [\"25480036\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Small patient cohort\", \"No rescue experiment with wild-type MCM9 in patient cells\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Discovery that MCM9 assembles with MMR factors (MSH2, MLH1, PMS1, RFC) and that its helicase activity is required for mismatch repair revealed a second, independent genome-maintenance function for MCM9 beyond HR.\",\n      \"evidence\": \"Co-immunoprecipitation, MMR activity assay in cell extracts, helicase-dead mutagenesis and knockout rescue, microsatellite instability assay\",\n      \"pmids\": [\"26300262\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MMR and HR functions use the same MCM8-MCM9 complex or distinct assemblies unclear\", \"Biochemical reconstitution of MCM9-dependent MMR not performed\", \"MMR role not yet validated in vivo in mice\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Genetic epistasis showed MCM9 promotes primordial germ-cell proliferation through a pathway distinct from FANCM, and independently of ATM-CHK2-p53-p21 signaling, refining the understanding of MCM9's gametogenesis role.\",\n      \"evidence\": \"Mouse genetics, Mcm9/Fancm double mutants, BrdU proliferation and apoptosis assays\",\n      \"pmids\": [\"26388201\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the MCM9-dependent proliferation signal unknown\", \"Whether germ-cell defect is solely due to HR or also MMR impairment not distinguished\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"HROB was identified as the factor that loads the MCM8-MCM9 helicase at damage sites, acting redundantly with HELQ, answering the long-standing question of how the complex is recruited to HR intermediates.\",\n      \"evidence\": \"Co-immunoprecipitation, HR reporter assay, mouse knockout phenocopying MCM8/9 infertility, epistasis with HELQ\",\n      \"pmids\": [\"31467087\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of HROB-MCM8/9 interaction unknown\", \"Whether HROB is also required for MCM9's MMR function not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"HORMAD1 was shown to sequester MCM8-MCM9 and impair its nuclear localization, linking cancer-associated HORMAD1 misexpression to MMR deficiency through MCM9, connecting germ-cell biology to tumor MMR phenotypes.\",\n      \"evidence\": \"Co-immunoprecipitation, immunofluorescence, chromatin fractionation for MLH1, MMR assay in HORMAD1-expressing cancer cells\",\n      \"pmids\": [\"32647118\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab observation not independently replicated\", \"HORMAD1-MCM8/9 interaction domain not mapped\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Mapping of the MCM9 C-terminal extension identified a bipartite NLS required for nuclear import of both MCM8 and MCM9, and a BRC-variant motif that directly binds RAD51, explaining the molecular mechanism by which MCM9 promotes RAD51 recruitment.\",\n      \"evidence\": \"Domain mutagenesis of NLS and BRCv, immunofluorescence, co-immunoprecipitation, MCM9 knockout and patient cell assays\",\n      \"pmids\": [\"33539926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of BRCv-RAD51 interface not determined\", \"Whether BRCv is sufficient for RAD51 filament remodeling unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"MCM9 was shown to interact with MSH2 and MLH1 in human testis and to be enriched in spermatogonial stem cells; loss-of-function mutations cause Sertoli cell-only syndrome in human males, establishing a direct clinical link between MCM9 and male infertility.\",\n      \"evidence\": \"Co-immunoprecipitation from human testicular tissue, immunohistochemistry, HR repair assay in HEK293T knockout and mutant cells\",\n      \"pmids\": [\"40593474\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Small patient cohort\", \"Whether the infertility phenotype is driven by HR, MMR, or both is unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of MCM8-MCM9 hexamerization and its helicase mechanism on recombination intermediates, whether MMR and HR employ the same or distinct MCM9-containing complexes, and the molecular basis by which MCM9 loss selectively depletes germ cells while leaving somatic viability largely intact.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of the MCM8-MCM9 complex\", \"In vivo reconstitution of MCM9-dependent MMR not performed\", \"Tissue-specific regulation of MCM9 expression poorly characterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [2, 6, 12]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 2, 4, 10]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [0, 4, 5, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [1, 2, 4, 6, 8, 10]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [6, 7, 14]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [1, 3, 14]}\n    ],\n    \"complexes\": [\n      \"MCM8-MCM9 helicase complex\",\n      \"MCM9-MSH2-MLH1-PMS1-RFC MMR complex\"\n    ],\n    \"partners\": [\n      \"MCM8\",\n      \"MSH2\",\n      \"MLH1\",\n      \"PMS1\",\n      \"RAD51\",\n      \"HROB\",\n      \"FANCD2\",\n      \"HORMAD1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}